Registration Dossier

Administrative data

Description of key information

No hazard was identified after one administration by oral or dermal route in rodents according to OECD tests nĀ° 423 and 402 (tests were performed with the registered substance at 25%)

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
2 000 mg/kg bw
Quality of whole database:
Klimich 1: the study was conducted according to OECD guideline 423, GLP study

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
2 000 mg/kg bw
Quality of whole database:
Klimich 1: the study was conducted according to OECD guideline 402, GLP study

Additional information

Justification for selection of acute toxicity ā€“ inhalation endpoint
Acute toxicity data are already available for the oral route and for the dermal route.
Vapor pressure is expected to be low

Justification for classification or non-classification

The registered substance is not classified for health